
Fatima Cody Stanford
Dr. Fatima Cody Stanford is an esteemed obesity medicine physician at Massachusetts General Hospital and an instructor at Harvard Medical School. She specializes in the treatment of obesity and related disorders, and her research often explores innovative approaches to weight management and metabolic health. Recently, she commented on a study highlighting the potential benefits of glucagon-like peptide-1 (GLP-1) agonists, suggesting that these weight-loss medications could also play a significant role in managing alcohol use disorder. Dr. Stanford's insights are valuable in advancing the understanding of obesity medicine and its implications for broader health issues.
Not in the pool (under ¢1).
Recent news mentions
Fatima Cody Stanford, an obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School, told USA Today that a softer start lowers the activation energy for behavior change.
75 Hard viral fitness challenge sparks expert warnings about sustainabilityDr Fatima Cody Stanford is a Massachusetts General Hospital obesity expert who emphasizes the importance of having options available to patients.
US regulators approve Wegovy pill, first oral medication to treat obesity | US healthcare
Dr. Fatima Cody Stanford, obesity medicine physician at Massachusetts General Hospital and Harvard Medical School, commented on the study's findings.
Study reveals additional health perk of weight-loss medications








